<?xml version="1.0" encoding="UTF-8"?>
<document id="29108267">
	<sentence id="s1" text="Down regulation of Protein Kinase D1 (PrKD1), a novel serine threonine kinase, in prostate, gastric, breast and colon cancers in humans leads to disease progression.">
		<entity id="s1.e1" charOffset="38-43"
			type="GENE" text="PrKD1" ontology_id="5587"/>
		<entity id="s1.e2" charOffset="118-124"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="While the down regulation of PrKD1 by DNA methylation in gastric cancer and by nuclear beta-catenin in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.">
		<entity id="s2.e1" charOffset="29-34"
			type="GENE" text="PrKD1" ontology_id="5587"/>
		<entity id="s2.e2" charOffset="65-71"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="87-99"
			type="GENE" text="beta-catenin" ontology_id="1499"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="true"/>
	</sentence>
	<sentence id="s3" text="Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of li>PrKD1.">
		<entity id="s3.e1" charOffset="33-38"
			type="GENE" text="PrKD1" ontology_id="5587"/>
		<entity id="s3.e2" charOffset="105-117"
			type="GENE" text="beta-catenin" ontology_id="1499"/>
		<entity id="s3.e3" charOffset="130-136"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="true"/>
	</sentence>
	<sentence id="s4" text="In silico human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates li>PrKD1 gene expression.">
		<entity id="s4.e1" charOffset="74-79"
			type="GENE" text="PrKD1" ontology_id="5587"/>
		<entity id="s4.e2" charOffset="103-109"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s4.e3" charOffset="154-157"
			type="GENE" text="MAX" ontology_id="4149"/>
		<entity id="s4.e4" charOffset="167-170"
			type="GENE" text="MYC" ontology_id="4609"/>
		<entity id="s4.e5" charOffset="192-196"
			type="GENE" text="MXD1" ontology_id="4084"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e4" pgr="true"/>
		<pair id="s4.p3" e1="s4.e2"
		    e2="s4.e3" pgr="true"/>
		<pair id="s4.p4" e1="s4.e2"
		    e2="s4.e5" pgr="false"/>
	</sentence>
</document>
